Treatment approaches for older patients with MCL

Fracture risk in older DLBCL patients after R-CHOP

Dr. Leslie on Frontline Treatment Options in Follicular Lymphoma

Newly Diagnosed DLBCL: Treatment Decision Factors

Is frontline R-CHOP still the standard of care for DLBCL?

Treatment options for DLBCL

Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL)

Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for t...

Treatment Innovation in DLBCL: Real-World Insight on Integrating Antibodies and Cellular Therapy

Treatment Alternatives to Chemotherapy in R/R DLBCL

Debate: Is Maintenance Therapy of value following frontline treatment for advanced DLBCL - No

How I approach the initial treatment of mantle cell lymphoma

Current Upfront Management of DLBCL

Double-hit DLBCL

How Is Diffuse Large B-Cell Lymphoma (DLBCL) Treated?

Association of interim PET2 response with outcomes in patients with DLBCL

The Next Phase of Targeted Therapy in MCL and DLBCL

What are the Hurdles to Using Cell of Origin in Classification to Treat DLBCL?

Perspectives on Novel Antibody Platforms in DLBCL

How to treat newly diagnosed DLBCL